scholarly article | Q13442814 |
P50 | author | Christopher R. Kelsey | Q43215897 |
Nelson J Chao | Q88101634 | ||
Mitchell E Horwitz | Q88550273 | ||
David Rizzieri | Q92624494 | ||
Ashley M Engemann | Q114516171 | ||
Martha Lassiter | Q114516175 | ||
P2093 | author name string | Samantha Thomas | |
Sarah J Stephens | |||
P2860 | cites work | Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant | Q28236952 |
Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission | Q28305230 | ||
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials | Q34608688 | ||
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation | Q35023409 | ||
Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia | Q35202316 | ||
Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study | Q35892403 | ||
Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. | Q37370649 | ||
Cord blood transplant for acute myeloid leukaemia | Q38696346 | ||
Bone marrow transplantation as the treatment of choice for "good risk" adult patients with acute leukemia | Q41195961 | ||
Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis | Q43200457 | ||
Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first compl | Q43629955 | ||
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies | Q43819615 | ||
Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission | Q44242611 | ||
Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia | Q46510867 | ||
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. | Q51749077 | ||
Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osse | Q68126425 | ||
A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosphamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: a Southwest Oncology Group st | Q70656728 | ||
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for B | Q71127546 | ||
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group | Q72384744 | ||
Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia | Q73231074 | ||
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Trans | Q74632699 | ||
Survival, disease-free survival and adverse effects of conditioning for allogeneic bone marrow transplantation with busulfan/cyclophosphamide vs total body irradiation: a meta-analysis | Q77227206 | ||
Acute myeloid leukemia | Q83584384 | ||
P433 | issue | 4 | |
P304 | page(s) | 272-280 | |
P577 | publication date | 2016-07-15 | |
P1433 | published in | Advances in radiation oncology | Q27727236 |
P1476 | title | Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity | |
P478 | volume | 1 |